Laser Doppler imaging - A new technique for quantifying microcirculatory flow in patients with primary Raynaud's phenomenon and systemic sclerosis

被引:49
作者
Clark, S [1 ]
Campbell, F
Moore, T
Jayson, MIV
King, TA
Herrick, AL
机构
[1] Hope Hosp, Ctr Rheumat Dis, Salford M6 8HD, Lancs, England
[2] Univ Manchester, Dept Phys & Astron, Manchester M13 9PL, Lancs, England
[3] Hope Hosp, Res & Dev Support Unit, Salford M6 8HD, Lancs, England
关键词
systemic sclerosis; Raynaud's phenomenon; laser Doppler imaging;
D O I
10.1006/mvre.1998.2124
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
This was a pilot study to investigate the new technique of laser Doppler imaging (scanning laser Doppler) as a tool to quantify microvascular blood now in the digits of patients with primary Raynaud's phenomenon (PRP) and systemic sclerosis (SSc), and to determine in the first instance whether the flux patterns obtained differ between patients with SSc, patients with PRP, and healthy control subjects. Laser Doppler images of the dorsum of the hand and fingers were acquired at 23 and 30 degrees C in 17 healthy control subjects, 7 patients with PRP, 9 patients with the diffuse cutaneous variant of SSc, and 24 patients with the limited cutaneous variant of SSc. Different flux parameters were compared between groups. Analysis of variance found significant differences between groups in two tests: maximum difference in flux between fingertips of the same hand at 23 degrees C (P = 0.001) and maximum gradient in flux along a finger ("distal-dorsal" flux difference) at 30 degrees C (P = 0.019). Post hoc tests highlighted the differences between controls and patients with limited cutaneous SSc. This pilot study suggests that laser Doppler imaging may allow objective measurement of microvascular now in patients with PRP and SSc. This new technique may overcome many of the problems inherent in single-channel laser Doppler equipment. (C) 1999 Academic Press.
引用
收藏
页码:284 / 291
页数:8
相关论文
共 50 条
  • [21] PLASMA IRISIN AND HEAT SHOCK PROTEIN 70 LEVELS IN PRIMARY RAYNAUD'S PHENOMENON AND SYSTEMIC SCLEROSIS
    Gozel, Nevzat
    Karatas, Ahmet
    Yardim, Meltem
    Kinaci, Mesude Seda
    Ulu, Ramazan
    Demircan, Fatih
    Kilinc, Faruk
    Ozdemir, Fethi Ahmet
    Aydin, Suleyman
    Koca, Suleyman Serdar
    FRESENIUS ENVIRONMENTAL BULLETIN, 2018, 27 (05): : 3180 - 3184
  • [22] Pharmacokinetics of oral iloprost in patients with Raynaud's phenomenon secondary to systemic sclerosis
    Janssen, MCH
    Wollersheim, H
    Kraus, C
    Hildebrand, M
    Watson, HR
    Thien, T
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2000, 60 (4-6): : 153 - 160
  • [23] Antioxidant status after iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis
    Balbir-Gurman, Alexandra
    Braun-Moscovici, Yolanda
    Livshitz, Vladimir
    Schapira, Daniel
    Markovits, Doron
    Rozin, Alexander
    Boikaner, Tatiana
    Nahir, A. Menahem
    CLINICAL RHEUMATOLOGY, 2007, 26 (09) : 1517 - 1521
  • [24] Efficacy of bosentan in the treatment of Raynaud's phenomenon in patients with systemic sclerosis never treated with prostanoids
    Parisi, S.
    Bruzzone, M.
    Di Vittorio, C. Centanaro
    Lagana, A.
    Peroni, C. L.
    Fusaro, E.
    REUMATISMO, 2013, 65 (06) : 286 - 291
  • [25] Novel photoplethysmography cardiovascular assessments in patients with Raynaud's phenomenon and systemic sclerosis: a pilot study
    McKay, Neil D.
    Griffiths, Bridget
    Di Maria, Costanzo
    Hedley, Stephen
    Murray, Alan
    Allen, John
    RHEUMATOLOGY, 2014, 53 (10) : 1855 - 1863
  • [26] Antioxidant status after iloprost treatment in patients with Raynaud’s phenomenon secondary to systemic sclerosis
    Alexandra Balbir-Gurman
    Yolanda Braun-Moscovici
    Vladimir Livshitz
    Daniel Schapira
    Doron Markovits
    Alexander Rozin
    Tatiana Boikaner
    A. Menahem Nahir
    Clinical Rheumatology, 2007, 26 : 1517 - 1521
  • [27] The value of pattern capillary changes and antibodies to predict the development of systemic sclerosis in patients with primary Raynaud’s phenomenon
    Slavica R. Pavlov-Dolijanovic
    Nemanja S. Damjanov
    Nada Z. Vujasinovic Stupar
    Snezana Baltic
    Dragan D. Babic
    Rheumatology International, 2013, 33 : 2967 - 2973
  • [28] The value of pattern capillary changes and antibodies to predict the development of systemic sclerosis in patients with primary Raynaud's phenomenon
    Pavlov-Dolijanovic, Slavica R.
    Damjanov, Nemanja S.
    Vujasinovic Stupar, Nada
    Baltic, Snezana
    Babic, Dragan D.
    RHEUMATOLOGY INTERNATIONAL, 2013, 33 (12) : 2967 - 2973
  • [29] Non-invasive assessment of digital vascular reactivity in patients with primary Raynaud's phenomenon and systemic sclerosis
    Anderson, ME
    Campbell, F
    Hollis, S
    Moore, T
    Jayson, MIV
    Herrick, AL
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1999, 17 (01) : 49 - 54
  • [30] The association between endothelial microparticles and inflammation in patients with systemic sclerosis and Raynaud's phenomenon as detected by functional imaging
    Jung, Christian
    Drummer, Karl
    Oelzner, Peter
    Figulla, Hans R.
    Boettcher, Joachim
    Franz, Marcus
    Betge, Stefan
    Foerster, Martin
    Wolf, Gunter
    Pfeil, Alexander
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2015, 61 (03) : 549 - 557